{"id":89876,"date":"2020-04-22T19:13:34","date_gmt":"2020-04-22T19:13:34","guid":{"rendered":"https:\/\/raed.academy\/?p=89876"},"modified":"2020-04-24T16:24:43","modified_gmt":"2020-04-24T16:24:43","slug":"remdesivir-per-a-pacients-amb-covid-19-greu","status":"publish","type":"post","link":"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/","title":{"rendered":"Remdesivir per a pacients amb Covid-19 greu"},"content":{"rendered":"<p><em>La prestigiosa revista cient\u00edfica brit\u00e0nica <strong>&#8220;The New England Journal of Medicine&#8221;<\/strong> ha alliberat tots els articles relacionats amb el coronavirus. En el seu afany per difondre la m\u00e0xima informaci\u00f3 cient\u00edfica sobre la pand\u00e8mia, dins del marc de la campanya <strong>&#8220;El coronavirus des del coneixement&#8221;<\/strong>, la <strong>Fundaci\u00f3 Pro Reial Acad\u00e8mia Europea de Doctors<\/strong> i la <strong>Reial Acad\u00e8mia Europea de Doctors-Barcelona 1914<\/strong> (RAED), posen les seves pataformes a disposici\u00f3 d&#8217;institucions de gran prestigi cient\u00edfic per difondre les seves publicacions.<\/em><\/p>\n<h3>Remdesivir per a pacients amb Covid-19 greu<\/h3>\n<p><strong>ABSTRACT<\/strong><\/p>\n<p><strong>Antecedents<\/strong><\/p>\n<p>Remdesivir, un prof\u00e0rmac an\u00e0leg de nucle\u00f2tid que inhibeix les ARN polimerases virals, ha mostrat una funcionalitat in vitro contra la SARS-CoV-2.<\/p>\n<p><strong>Metodologia<\/strong><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-89887\" src=\"https:\/\/raed.academy\/wp-content\/uploads\/2020\/04\/Remdesivir-dstNtc.jpg\" alt=\"Remdesivir\" width=\"401\" height=\"229\" data-attachment-id=\"89887\" data-permalink=\"https:\/\/raed.academy\/remdesivir-para-pacientes-con-covid-19-grave\/remdesivir-dstntc\/\" data-orig-file=\"https:\/\/raed.academy\/wp-content\/uploads\/2020\/04\/Remdesivir-dstNtc.jpg\" data-orig-size=\"600,343\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"Remdesivir-dstNtc\" data-image-description=\"\" data-medium-file=\"https:\/\/raed.academy\/wp-content\/uploads\/2020\/04\/Remdesivir-dstNtc.jpg\" data-large-file=\"https:\/\/raed.academy\/wp-content\/uploads\/2020\/04\/Remdesivir-dstNtc.jpg\" \/>Proporcionem Remdesivir a pacients hospitalitzats amb Covid-19, la malaltia causada per la infecci\u00f3 per SARS-CoV-2. Els pacients eren aquells amb infecci\u00f3 confirmada per SARS-CoV-2 que tenien una saturaci\u00f3 d&#8217;oxigen del 94% o menys mentre respiraven aire ambient o rebien oxigen. Els pacients van rebre un cicle de remdesivir de 10 dies, que consistia en 200 mg administrats per via intravenosa el dia 1, seguits de 100 mg diaris durant els 9 dies restants de tractament. Aquest informe es basa en dades de pacients que van rebre Remdesivir durant el per\u00edode compr\u00e8s entre el 25 de gener de 2020 i el 7 de mar\u00e7 de 2020, i tenen dades cl\u00edniques de al menys 1 dia posterior.<\/p>\n<p><strong>Resultats<\/strong><\/p>\n<p>Dels 61 pacients que van rebre almenys una dosi de Remdesivir no es van poder analitzar les dades de 8 (inclosos 7 pacients sense dades posteriors al tractament i 1 amb un error de dosificaci\u00f3). Dels 53 pacients les dades van ser analitzats, 22 es trobaven als Estats Units, 22 a Europa o el Canad\u00e0 i 9 al Jap\u00f3. A l&#8217;inici de l&#8217;estudi, 30 pacients (57%) rebien ventilaci\u00f3 mec\u00e0nica i 4 (8%) rebien oxigenaci\u00f3 per membrana extracorp\u00f2ria. Durant una mitjana de seguiment de 18 dies, 36 pacients (68%) van tenir una millora en la classe de suport d&#8217;oxigen, inclosos 17 de 30 pacients (57%) que van rebre ventilaci\u00f3 mec\u00e0nica que van ser extubats. Un total de 25 pacients (47%) van ser donats d&#8217;alta i 7 pacients (13%) van morir; la mortalitat va ser del 18% (6 de 34) entre els pacients que van rebre ventilaci\u00f3 invasiva i del 5% (1 de 19) entre els que no van rebre ventilaci\u00f3 invasiva.<\/p>\n<p><strong>Conclusions<\/strong><\/p>\n<p>En aquesta mostra de pacients hospitalitzats per Covid-19 greu que van ser tractats amb Remdesivir es va observar una millora cl\u00ednica en 36 de 53 pacients (68%). El mesurament de l&#8217;efic\u00e0cia requerir\u00e0 assaigs aleatoris en curs controlats amb placebo de la ter\u00e0pia amb Remdesivir. (Estudi finan\u00e7at per <strong>Gilead Sciences<\/strong>).<\/p>\n<h3><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2007016?query=featured_home\" target=\"_blank\" rel=\"noopener noreferrer\">Llegir article sencer (en angl\u00e8s)<\/a><\/h3>\n","protected":false},"excerpt":{"rendered":"<p>La prestigiosa revista cient\u00edfica brit\u00e0nica &#8220;The New England Journal of Medicine&#8221; ha alliberat tots els articles relacionats amb el coronavirus. En el seu afany per difondre la m\u00e0xima informaci\u00f3 cient\u00edfica sobre la pand\u00e8mia, dins del marc de la campanya &#8220;El coronavirus des del coneixement&#8221;, la Fundaci\u00f3 Pro Reial Acad\u00e8mia Europea de Doctors i la Reial [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":89888,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[268,273],"tags":[],"class_list":["post-89876","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-coronavirus-des-del-coneixement","category-salut","et-has-post-format-content","et_post_format-et-post-format-standard"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Remdesivir per a pacients amb Covid-19 greu - Reial Acad\u00e8mia Europea de Doctors<\/title>\n<meta name=\"description\" content=\"Remdesivir, un prof\u00e0rmac an\u00e0leg de nucle\u00f2tid que inhibeix les ARN polimerases virals, ha mostrat una funcionalitat in vitro contra la SARS-CoV-2\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Remdesivir per a pacients amb Covid-19 greu - Reial Acad\u00e8mia Europea de Doctors\" \/>\n<meta property=\"og:description\" content=\"Remdesivir, un prof\u00e0rmac an\u00e0leg de nucle\u00f2tid que inhibeix les ARN polimerases virals, ha mostrat una funcionalitat in vitro contra la SARS-CoV-2\" \/>\n<meta property=\"og:url\" content=\"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/\" \/>\n<meta property=\"og:site_name\" content=\"Reial Acad\u00e8mia Europea de Doctors\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/fb.me\/raed.academy\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-22T19:13:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-04-24T16:24:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/raed.academy\/wp-content\/uploads\/2020\/04\/Remdesivir-dstNtc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"343\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"RAED\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@raedacademy\" \/>\n<meta name=\"twitter:site\" content=\"@raedacademy\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"RAED\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/remdesivir-per-a-pacients-amb-covid-19-greu\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/remdesivir-per-a-pacients-amb-covid-19-greu\\\/\"},\"author\":{\"name\":\"RAED\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#\\\/schema\\\/person\\\/5a755da80d1d979fd66ba745c8702927\"},\"headline\":\"Remdesivir per a pacients amb Covid-19 greu\",\"datePublished\":\"2020-04-22T19:13:34+00:00\",\"dateModified\":\"2020-04-24T16:24:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/remdesivir-per-a-pacients-amb-covid-19-greu\\\/\"},\"wordCount\":432,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/remdesivir-per-a-pacients-amb-covid-19-greu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/Remdesivir-dstNtc.jpg\",\"articleSection\":[\"Coronavirus des del coneixement\",\"Salut\"],\"inLanguage\":\"ca-ES\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/raed.academy\\\/ca\\\/remdesivir-per-a-pacients-amb-covid-19-greu\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/remdesivir-per-a-pacients-amb-covid-19-greu\\\/\",\"url\":\"https:\\\/\\\/raed.academy\\\/ca\\\/remdesivir-per-a-pacients-amb-covid-19-greu\\\/\",\"name\":\"Remdesivir per a pacients amb Covid-19 greu - Reial Acad\u00e8mia Europea de Doctors\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/remdesivir-per-a-pacients-amb-covid-19-greu\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/remdesivir-per-a-pacients-amb-covid-19-greu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/Remdesivir-dstNtc.jpg\",\"datePublished\":\"2020-04-22T19:13:34+00:00\",\"dateModified\":\"2020-04-24T16:24:43+00:00\",\"description\":\"Remdesivir, un prof\u00e0rmac an\u00e0leg de nucle\u00f2tid que inhibeix les ARN polimerases virals, ha mostrat una funcionalitat in vitro contra la SARS-CoV-2\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/remdesivir-per-a-pacients-amb-covid-19-greu\\\/#breadcrumb\"},\"inLanguage\":\"ca-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/raed.academy\\\/ca\\\/remdesivir-per-a-pacients-amb-covid-19-greu\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca-ES\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/remdesivir-per-a-pacients-amb-covid-19-greu\\\/#primaryimage\",\"url\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/Remdesivir-dstNtc.jpg\",\"contentUrl\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/Remdesivir-dstNtc.jpg\",\"width\":600,\"height\":343,\"caption\":\"Remdesivir\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/remdesivir-per-a-pacients-amb-covid-19-greu\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/raed.academy\\\/ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Remdesivir per a pacients amb Covid-19 greu\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#website\",\"url\":\"https:\\\/\\\/raed.academy\\\/ca\\\/\",\"name\":\"Reial Acad\u00e8mia Europea de Doctors\",\"description\":\"Corporaci\u00f3n de derecho p\u00fablico de car\u00e1cter cient\u00edfico, t\u00e9cnico y art\u00edstico, que tiene por objeto la investigaci\u00f3n, el estudio, el fomento y la extensi\u00f3n del conocimiento en su sentido m\u00e1s amplio\",\"publisher\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/raed.academy\\\/ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#organization\",\"name\":\"Real Academia Europea de Doctores\",\"url\":\"https:\\\/\\\/raed.academy\\\/ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca-ES\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/cropped-logo_raed.png\",\"contentUrl\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/cropped-logo_raed.png\",\"width\":512,\"height\":512,\"caption\":\"Real Academia Europea de Doctores\"},\"image\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"http:\\\/\\\/fb.me\\\/raed.academy\",\"https:\\\/\\\/x.com\\\/raedacademy\",\"https:\\\/\\\/www.instagram.com\\\/raed.academy\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCUYQwW2KrdirNWihxMDObwg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#\\\/schema\\\/person\\\/5a755da80d1d979fd66ba745c8702927\",\"name\":\"RAED\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca-ES\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g\",\"caption\":\"RAED\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Remdesivir per a pacients amb Covid-19 greu - Reial Acad\u00e8mia Europea de Doctors","description":"Remdesivir, un prof\u00e0rmac an\u00e0leg de nucle\u00f2tid que inhibeix les ARN polimerases virals, ha mostrat una funcionalitat in vitro contra la SARS-CoV-2","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/","og_locale":"ca_ES","og_type":"article","og_title":"Remdesivir per a pacients amb Covid-19 greu - Reial Acad\u00e8mia Europea de Doctors","og_description":"Remdesivir, un prof\u00e0rmac an\u00e0leg de nucle\u00f2tid que inhibeix les ARN polimerases virals, ha mostrat una funcionalitat in vitro contra la SARS-CoV-2","og_url":"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/","og_site_name":"Reial Acad\u00e8mia Europea de Doctors","article_publisher":"http:\/\/fb.me\/raed.academy","article_published_time":"2020-04-22T19:13:34+00:00","article_modified_time":"2020-04-24T16:24:43+00:00","og_image":[{"width":600,"height":343,"url":"https:\/\/raed.academy\/wp-content\/uploads\/2020\/04\/Remdesivir-dstNtc.jpg","type":"image\/jpeg"}],"author":"RAED","twitter_card":"summary_large_image","twitter_creator":"@raedacademy","twitter_site":"@raedacademy","twitter_misc":{"Written by":"RAED","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/#article","isPartOf":{"@id":"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/"},"author":{"name":"RAED","@id":"https:\/\/raed.academy\/ca\/#\/schema\/person\/5a755da80d1d979fd66ba745c8702927"},"headline":"Remdesivir per a pacients amb Covid-19 greu","datePublished":"2020-04-22T19:13:34+00:00","dateModified":"2020-04-24T16:24:43+00:00","mainEntityOfPage":{"@id":"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/"},"wordCount":432,"commentCount":0,"publisher":{"@id":"https:\/\/raed.academy\/ca\/#organization"},"image":{"@id":"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/#primaryimage"},"thumbnailUrl":"https:\/\/raed.academy\/wp-content\/uploads\/2020\/04\/Remdesivir-dstNtc.jpg","articleSection":["Coronavirus des del coneixement","Salut"],"inLanguage":"ca-ES","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/","url":"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/","name":"Remdesivir per a pacients amb Covid-19 greu - Reial Acad\u00e8mia Europea de Doctors","isPartOf":{"@id":"https:\/\/raed.academy\/ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/#primaryimage"},"image":{"@id":"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/#primaryimage"},"thumbnailUrl":"https:\/\/raed.academy\/wp-content\/uploads\/2020\/04\/Remdesivir-dstNtc.jpg","datePublished":"2020-04-22T19:13:34+00:00","dateModified":"2020-04-24T16:24:43+00:00","description":"Remdesivir, un prof\u00e0rmac an\u00e0leg de nucle\u00f2tid que inhibeix les ARN polimerases virals, ha mostrat una funcionalitat in vitro contra la SARS-CoV-2","breadcrumb":{"@id":"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/#breadcrumb"},"inLanguage":"ca-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/"]}]},{"@type":"ImageObject","inLanguage":"ca-ES","@id":"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/#primaryimage","url":"https:\/\/raed.academy\/wp-content\/uploads\/2020\/04\/Remdesivir-dstNtc.jpg","contentUrl":"https:\/\/raed.academy\/wp-content\/uploads\/2020\/04\/Remdesivir-dstNtc.jpg","width":600,"height":343,"caption":"Remdesivir"},{"@type":"BreadcrumbList","@id":"https:\/\/raed.academy\/ca\/remdesivir-per-a-pacients-amb-covid-19-greu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/raed.academy\/ca\/"},{"@type":"ListItem","position":2,"name":"Remdesivir per a pacients amb Covid-19 greu"}]},{"@type":"WebSite","@id":"https:\/\/raed.academy\/ca\/#website","url":"https:\/\/raed.academy\/ca\/","name":"Reial Acad\u00e8mia Europea de Doctors","description":"Corporaci\u00f3n de derecho p\u00fablico de car\u00e1cter cient\u00edfico, t\u00e9cnico y art\u00edstico, que tiene por objeto la investigaci\u00f3n, el estudio, el fomento y la extensi\u00f3n del conocimiento en su sentido m\u00e1s amplio","publisher":{"@id":"https:\/\/raed.academy\/ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/raed.academy\/ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca-ES"},{"@type":"Organization","@id":"https:\/\/raed.academy\/ca\/#organization","name":"Real Academia Europea de Doctores","url":"https:\/\/raed.academy\/ca\/","logo":{"@type":"ImageObject","inLanguage":"ca-ES","@id":"https:\/\/raed.academy\/ca\/#\/schema\/logo\/image\/","url":"https:\/\/raed.academy\/wp-content\/uploads\/2017\/01\/cropped-logo_raed.png","contentUrl":"https:\/\/raed.academy\/wp-content\/uploads\/2017\/01\/cropped-logo_raed.png","width":512,"height":512,"caption":"Real Academia Europea de Doctores"},"image":{"@id":"https:\/\/raed.academy\/ca\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/fb.me\/raed.academy","https:\/\/x.com\/raedacademy","https:\/\/www.instagram.com\/raed.academy\/","https:\/\/www.youtube.com\/channel\/UCUYQwW2KrdirNWihxMDObwg"]},{"@type":"Person","@id":"https:\/\/raed.academy\/ca\/#\/schema\/person\/5a755da80d1d979fd66ba745c8702927","name":"RAED","image":{"@type":"ImageObject","inLanguage":"ca-ES","@id":"https:\/\/secure.gravatar.com\/avatar\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g","caption":"RAED"}}]}},"_links":{"self":[{"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/posts\/89876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/comments?post=89876"}],"version-history":[{"count":0,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/posts\/89876\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/media\/89888"}],"wp:attachment":[{"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/media?parent=89876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/categories?post=89876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/tags?post=89876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}